Literature DB >> 35016334

Effect of Poly(sophorolipid) Functionalization on Human Mesenchymal Stem Cell Osteogenesis and Immunomodulation.

Ahmad S Arabiyat, Patricia Diaz-Rodriguez, Josh D Erndt-Marino, Filbert Totsingan, Shekar Mekala, Richard A Gross, Mariah S Hahn.   

Abstract

Sophorolipids are a class of glycolipids that can be polymerized via ring-opening metathesis polymerization giving rise to bioresorbable biomaterials. The surface chemistry of the resulting poly(sophorolipids) (pLSLs) can be modified using a combination of enzymatic and "click" chemistries to insert bioactive groups that influence cellular behavior. Mesenchymal stem cells (MSCs) are being actively investigated for engineered bone grafts for fracture repair due to their osteogenic potential, and more recently, due to their immunomodulatory capacity. The long-term goal of this work is to utilize functionalized pLSL foams loaded with MSCs as bioresorbable scaffolds for bone fracture healing. Toward this goal, the present study evaluated the effect of various pLSL chemistries on the osteogenic and immunomodulatory behavior of MSCs. pLSLs functionalized with PO4, NH2, or COOH small functional groups were fabricated into open porous foams and then cultured with MSCs in the presence of osteogenic medium for 72 h. Protein level assessments demonstrated that the PO4-functionalized pLSL foams supported the highest degree of MSC osteogenesis as well as the highest levels of immunomodulatory factors pertinent to improve bone fracture healing. Cumulatively, these results suggest that further investigation of the long-term osteogenic commitment of MSCs in PO4-functionalized pLSL foams is warranted.

Entities:  

Keywords:  immunomodulation for bone fracture repair; mesenchymal stem cells; osteogenesis; poly(sophorolipids)

Year:  2018        PMID: 35016334     DOI: 10.1021/acsabm.8b00434

Source DB:  PubMed          Journal:  ACS Appl Bio Mater        ISSN: 2576-6422


  1 in total

1.  Small extracellular vesicles in combination with sleep-related circRNA3503: A targeted therapeutic agent with injectable thermosensitive hydrogel to prevent osteoarthritis.

Authors:  Shi-Cong Tao; Ji-Yan Huang; Yuan Gao; Zi-Xiang Li; Zhan-Ying Wei; Helen Dawes; Shang-Chun Guo
Journal:  Bioact Mater       Date:  2021-05-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.